Menu
GeneBe

3-10039303-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001018115.3(FANCD2):c.516A>G(p.Ile172Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00334 in 1,613,798 control chromosomes in the GnomAD database, including 172 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 95 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 77 hom. )

Consequence

FANCD2
NM_001018115.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: 0.263
Variant links:
Genes affected
FANCD2 (HGNC:3585): (FA complementation group D2) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016033947).
BP6
Variant 3-10039303-A-G is Benign according to our data. Variant chr3-10039303-A-G is described in ClinVar as [Benign]. Clinvar id is 134327.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-10039303-A-G is described in Lovd as [Benign]. Variant chr3-10039303-A-G is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0622 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FANCD2NM_001018115.3 linkuse as main transcriptc.516A>G p.Ile172Met missense_variant 8/44 ENST00000675286.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FANCD2ENST00000675286.1 linkuse as main transcriptc.516A>G p.Ile172Met missense_variant 8/44 NM_001018115.3 P2Q9BXW9-2

Frequencies

GnomAD3 genomes
AF:
0.0185
AC:
2821
AN:
152136
Hom.:
95
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0642
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00779
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.0158
GnomAD3 exomes
AF:
0.00462
AC:
1162
AN:
251288
Hom.:
39
AF XY:
0.00333
AC XY:
452
AN XY:
135808
show subpopulations
Gnomad AFR exome
AF:
0.0643
Gnomad AMR exome
AF:
0.00249
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000141
Gnomad OTH exome
AF:
0.00228
GnomAD4 exome
AF:
0.00176
AC:
2570
AN:
1461544
Hom.:
77
Cov.:
30
AF XY:
0.00154
AC XY:
1121
AN XY:
727094
show subpopulations
Gnomad4 AFR exome
AF:
0.0619
Gnomad4 AMR exome
AF:
0.00318
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000890
Gnomad4 OTH exome
AF:
0.00399
GnomAD4 genome
AF:
0.0186
AC:
2827
AN:
152254
Hom.:
95
Cov.:
32
AF XY:
0.0180
AC XY:
1343
AN XY:
74454
show subpopulations
Gnomad4 AFR
AF:
0.0642
Gnomad4 AMR
AF:
0.00778
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000132
Gnomad4 OTH
AF:
0.0157
Alfa
AF:
0.00321
Hom.:
27
Bravo
AF:
0.0216
ESP6500AA
AF:
0.0704
AC:
310
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00581
AC:
705
Asia WGS
AF:
0.00433
AC:
15
AN:
3478
EpiCase
AF:
0.0000546
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia complementation group D2 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
not provided Benign:2
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Benign, criteria provided, single submitterclinical testingGeneDxApr 03, 2019- -
not specified Benign:1Other:1
not provided, no classification providedreference populationITMISep 19, 2013- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Fanconi anemia Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Hereditary breast ovarian cancer syndrome Benign:1
Benign, criteria provided, single submitterclinical testingNational Health Laboratory Service, Universitas Academic Hospital and University of the Free StateApr 19, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.67
Cadd
Benign
16
Dann
Benign
0.75
Eigen
Benign
-0.84
Eigen_PC
Benign
-0.61
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.63
T;T;.;T
MetaRNN
Benign
0.0016
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-1.1
N;N;N;N
MutationTaster
Benign
1.0
N;N;N;N;N
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.47
N;N;N;N
REVEL
Benign
0.025
Sift
Benign
1.0
T;T;T;T
Sift4G
Benign
0.69
T;T;T;T
Polyphen
0.0070, 0.0020
.;B;B;B
Vest4
0.20
MVP
0.46
MPC
0.15
ClinPred
0.0019
T
GERP RS
1.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.047
gMVP
0.26

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35173688; hg19: chr3-10080987; COSMIC: COSV104599186; COSMIC: COSV104599186; API